These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 527147)

  • 1. Fate of hydralazine in man. I. Reactions under gastric conditions.
    Noda A; Matsuyama K; Yen SH; Sogabe K; Aso Y; Iguchi S; Noda H
    Chem Pharm Bull (Tokyo); 1979 Nov; 27(11):2820-6. PubMed ID: 527147
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitrosamine formation in human saliva.
    Tannenbaum SR; Archer MC; Wishnok JS; Bishop WW
    J Natl Cancer Inst; 1978 Feb; 60(2):251-3. PubMed ID: 621744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo.
    Johnson C; Stubley-Beedham C; Stell JG
    Biochem Pharmacol; 1985 Dec; 34(24):4251-6. PubMed ID: 3841000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone.
    Talseth T; Haegele KD; McNay JL; Skrdlant HB; Clementi WA; Shepherd AM
    J Pharmacol Exp Ther; 1979 Dec; 211(3):509-13. PubMed ID: 512915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of hydralazine in man. II. Formation of tetrazolo[5,1-a]phthalazine in vivo and inhibition of monoamine oxidase by this metabolite.
    Noda A; Noda H; Minemoto M; Zaitsu K; Ohkura Y; Iguchi S
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2683-5. PubMed ID: 7349285
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of hydrazine derived from hydralazine in experimental animals.
    Noda A; Matsuyama K; Yen SH; Otsuji N; Iguchi S; Noda H
    Chem Pharm Bull (Tokyo); 1979 Aug; 27(8):1938-41. PubMed ID: 540361
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of hydrallazine and hydrallazine hydrazone metabolites in human body fluids and quantitative in vitro comparisons of their smooth muscle relaxant activity.
    Haegele KD; McLean AJ; du Souich P; Barron K; Laquer J; McNay JL; Carrier O
    Br J Clin Pharmacol; 1978 Jun; 5(6):489-94. PubMed ID: 656292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation.
    Talseth T; Haegele KD; McNay JL
    Drug Metab Dispos; 1980; 8(2):73-6. PubMed ID: 6103791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of hydralazine.
    Israili ZH; Dayton PG
    Drug Metab Rev; 1977; 6(2):283-305. PubMed ID: 344023
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and quantitation of hydrazine in the urine of patients treated with hydralazine.
    Timbrell JA; Harland SJ
    Clin Pharmacol Ther; 1979 Jul; 26(1):81-8. PubMed ID: 445966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary constituents and nitrosamine formation in human saliva.
    Rao GS
    N Engl J Med; 1978 Jul; 299(4):202. PubMed ID: 26874
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxygen uptake during the mixing of saliva with ascorbic acid under acidic conditions: possibility of its occurrence in the stomach.
    Takahama U; Hirota S; Yamamoto A; Oniki T
    FEBS Lett; 2003 Aug; 550(1-3):64-8. PubMed ID: 12935887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione conjugates of hydralazine formed in the peroxidase/hydrogen peroxide/glutathione system.
    McGirr LG; O'Brien PJ
    Adv Exp Med Biol; 1991; 283():337-42. PubMed ID: 2069005
    [No Abstract]   [Full Text] [Related]  

  • 14. The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155).
    Cho AK; Curry SH
    Biochem Pharmacol; 1969 Feb; 18(2):511-20. PubMed ID: 5778161
    [No Abstract]   [Full Text] [Related]  

  • 15. The presence of 4-hydroxyphenylacetic acid in human saliva and the possibility of its nitration by salivary nitrite in the stomach.
    Takahama U; Oniki T; Murata H
    FEBS Lett; 2002 May; 518(1-3):116-8. PubMed ID: 11997029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of in vitro effects of hydralazine metabolites--comparative evaluation of products of hydroxylation, hydrolysis and conjugation.
    McLean AJ; du Souich P; Barron K; Carrier O; Haegele KD; McNay JL
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):19-25. PubMed ID: 736689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics.
    Singh B; Pahuja S; Kapil R; Ahuja N
    Acta Pharm; 2009 Mar; 59(1):1-13. PubMed ID: 19304554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic acetylation of hydralazine.
    Timbrell JA; Harland SJ; Facchini V
    Clin Pharmacol Ther; 1980 Sep; 28(3):350-5. PubMed ID: 7408395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of hydralazine elimination.
    Talseth T
    Clin Pharmacol Ther; 1977 Jun; 21(6):715-20. PubMed ID: 862310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous generation of hydralazine from labile hydralazine hydrazones.
    Clementi WA; McNay JL; Talseth T; Haegele KD; Ludden TM; Musgrave GE
    J Pharmacol Exp Ther; 1982 Jul; 222(1):159-65. PubMed ID: 7086698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.